← Blog
COMPLIANCERivvi · July 30, 2025 · Updated October 8, 2026 · 5 min read

2027 Medicare Star Ratings: what changed

CMS posted the 2027 Star Ratings on October 8, 2026. They are on Medicare Plan Finder for 2027 Open Enrollment, October 15 through December 7, 2026, and they affect 2028 quality bonus payments. They are not the bonus paid in 2027. The April 2026 final rule is a separate document: it dropped the planned health equity reward, kept the historical reward factor, and scheduled 11 measure removals for the 2028 and 2029 ratings. Those measures are still in the file posted today.

Turn your gap report into a call list

Upload the gap or adherence report and rank the members or patients to reach first. The free organization plan covers you and two colleagues, with a HIPAA BAA included. Calls and texts are on Team.

Takeaways

  1. The October 8 ratings pay the 2028 bonus

    About 71% of Medicare Advantage drug-plan enrollees are in contracts with 4 or more 2027 stars. Fifteen contracts earned the high-performing icon.

  2. The Health Equity Index is off

    CMS is not implementing the Excellent Health Outcomes for All reward. The historical reward factor stays.

  3. Three measures left this file

    Pain assessment, medication reconciliation post-discharge, and the comprehensive medication review rate are not 2027 star measures. Call center, appeals, and complaints are still in. They leave in 2028 or 2029.

  4. Patient experience counts less

    Those measures dropped from weight 4 to 2 starting with the 2026 Stars.

  5. Adherence stays at weight 3 in the 2027 ratings

    A finalized risk-adjustment change starts with the 2028 Stars. Consultant analyses expect that to drop adherence to weight 1 for that year, then back to 3. Confirm against the 2028 measures list when CMS posts it.

Why Star Ratings matter in dollars

Star Ratings score Medicare Advantage (MA) and Part D plans from 1 to 5 stars. Plans rated 4 stars or higher get quality bonus payments (QBP). See our Star Ratings glossary entry.

$13.4B

Quality bonus payments, 2026

Up from $12.7B in 2025 (KFF)

64%

MA-PD enrollees in 4+ star contracts

2026 Star Ratings (CMS)

3.98

Average MA-PD rating

Enrollment-weighted, 2026 (CMS)

KFF estimates Medicare will spend at least $13.4 billion on quality bonuses in 2026. About 68% of MA enrollees, nearly 24 million people, are in bonus-eligible plans. The figures in the grid are the 2026 ratings. In the 2027 ratings posted October 8, about 71% of MA-PD enrollees are in contracts with 4 or more stars. Those ratings pay the 2028 bonus.

CMS announced the final rule April 2, 2026. It was published April 6 and took effect June 1, 2026.

Health equity reward dropped, reward factor kept

CMS had planned a Health Equity Index (HEI), later renamed Excellent Health Outcomes for All (EHO4All). It would have replaced the reward factor with a bonus tied to how plans performed for members with social risk factors.

The final rule doesn't implement it. CMS keeps the historical reward factor, which rewards plans whose performance is both high and consistent across measures.

If you built a plan strategy around the HEI, set it aside. The goal is consistent high performance across the measures that count.

The measures CMS removed

CMS removed 11 measures, including these:

From the 2028 Star Ratings:

  • Call Center: Foreign Language Interpreter and TTY Availability (Parts C and D)
  • Statin Therapy for Patients with Cardiovascular Disease (Part C)

From the 2029 Star Ratings (2027 measurement period):

  • Plan Makes Timely Decisions about Appeals (Part C)
  • Reviewing Appeals Decisions (Part C)
  • Special Needs Plan (SNP) Care Management (Part C)
  • Complaints about the Health or Drug Plan (Parts C and D)
  • Medicare Plan Finder Price Accuracy (Part D)
  • Members Choosing to Leave the Plan (Parts C and D)
  • Customer Service (Part C)
  • Rating of Health Care Quality (Part C)

Kept: CMS proposed removing Diabetes Care: Eye Exam but kept it. Providers should keep closing that gap.

Removed outside this rule for 2027 Stars: Care for Older Adults Pain Assessment, Medication Reconciliation Post-Discharge, and MTM Completion Rate for Comprehensive Medication Review (CMR).

CMR is not a 2027 star measure. It is on the display page for measurement years 2025 and 2026. CMS says it returns as a new measure beginning with the 2029 Star Ratings. Pharmacies running MTM (medication therapy management) should keep doing CMRs. The measure is coming back. See our CMR glossary entry.

What the removals mean for the score

The overall rating is a weighted average. Take measures out and each remaining measure carries a bigger share. Most removals are customer service, appeals, complaints and survey items. That shifts the balance toward clinical measures and Part D adherence.

For plans, call center polish buys less than it used to. For the provider groups and pharmacies plans work with, the measures you directly affect now matter more. These include blood pressure control, diabetes control, eye exams and adherence. Expect plans to push those harder in 2027 contracts and incentive programs.

What the October 8 file added and removed

The 2027 measures PDF adds four measures at weight 1. Colorectal cancer screening was respecified and is treated as new. Care for Older Adults functional status assessment is back after a specification change and is also treated as new. Concurrent use of opioids and benzodiazepines, and polypharmacy of anticholinergic medications in older adults, are new Part D process measures.

Improving or Maintaining Physical Health and Improving or Maintaining Mental Health move from weight 1 in the 2026 ratings to weight 3. The three Part D adherence measures stay at weight 3 in this file.

Depression Screening and Follow-Up (Part C) is not in the October 8 star file. It is measured starting in 2027 and first counts in the 2029 Star Ratings. New measures carry weight 1 in their first year.

For provider groups, this is a measure you can act on now. The 2027 measurement year starts January 1.

How the weights are shifting

Weights decide how much each measure moves the overall rating. Under 42 CFR 422.166(e):

  • Outcome and intermediate-outcome measures: weight 3
  • Process measures: weight 1
  • New measures: weight 1 in their first year

Patient experience, complaints and access measures dropped from weight 4 to 2, starting with the 2026 Star Ratings. These include the CAHPS member survey measures. Combined with the removals above, survey and administrative measures carry less of the score.

Part D adherence covers 3 measures: diabetes medications, RAS antagonists (blood pressure drugs) and statins. Each is weighted 3 in the 2027 Star Ratings. A sociodemographic status (SDS) risk adjustment applies starting with the 2028 Star Ratings. CMS finalized it in the CY2024 Medicare Advantage and Part D final rule (CMS-4201-F, published April 12, 2023). CMS has not posted the 2028 weights. CMS treats a substantive specification change like a new measure for a year, so consultant analyses from Wakely and RISE expect the weights to work like this. CMS's 2028 measures list is the final word:

  1. Adherence at weight 3

    Diabetes, RAS antagonist and statin adherence each count triple.

  2. Adherence expected at weight 1

    SDS risk adjustment begins. Consultants expect the weight to drop for one year as a substantive change.

  3. Adherence back to weight 3

    Risk-adjusted measures return to triple weight.

Don't ease off adherence. Star Ratings lag performance by about two years: the 2029 Stars draw on the 2027 measurement period. So the fills your patients pick up next year count at weight 3 again.

What provider groups should prioritize

Plans pass Star Ratings pressure to the groups they contract with. Focus here:

  1. Clinical outcome measures. Blood pressure control and diabetes control carry weight 3 and still count.
  2. Diabetes eye exams. CMS kept the measure. Track it on your gap list.
  3. Depression screening. Build it into visits now for the 2027 measurement year.
  4. Annual wellness visits. The AWV is where many gaps get found and closed. Our AWV billing guide covers the codes.

What pharmacies should prioritize

  1. Adherence, every month. Proportion of days covered (PDC) at 80% or higher is the target. Our PDC improvement guide has the details.
  2. Keep doing CMRs. The measure returns in 2029 Stars.
  3. Statin use. Statin Therapy for Patients with CVD is out of Stars for 2028, but statin adherence still counts.

The work behind both lists is the same: reach the patient, find the barrier, fix it or route it. Southeast Medical Group has reached 104,000+ patients live with Rivvi across a multi-practice panel, with a 0.45% opt-out rate (figures as of August 2026). "In just 3 months with Rivvi we're already 2 to 3 points higher on medication adherence, and my staff finally make real impact instead of leaving voicemails," says Jennifer Saddanathan, PharmD, Director of Care Management at Southeast Medical Group.

On Rivvi's free organization plan, a plan or provider group can upload a gap or adherence report and ask which members or patients to reach first. On the Team plan, Rivvi calls and texts them. It warm-transfers anything clinical to a person, or creates a task. See how Rivvi supports Star Ratings and medication adherence work.

Sources

HIPAA compliant AI chatbots lists the tools that sign a BAA, and on which plan.

Try it on your own data today.

Free to start. Most teams are using it the same day.